Investors & Media

Price Change(%) Volume

Price Change(%) Volume

Event Details

MyoKardia Conference Call to Discuss Danicamtiv Phase 2a Study

June 22, 2020 at 8:30 AM EDT

Click here for webcast

Supporting Materials

Danicamtiv (MYK 491) A Novel Small Molecule Cardiac Activator: in vitro/in vivo Evidence for Overall Myocardial Inotropy

Phase 2a Study of Danicamtiv (MYK 491) in Patients with Chronic Heart Failure with Reduced Ejection Fraction ( HFrEF )